InsidersTradesSigma
CARDINAL HEALTH INC Stock: price and directors' dealings · United States · SEC (Form 4)
Track the CARDINAL HEALTH INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, CARDINAL HEALTH INC has published 194 public disclosures. Market capitalisation: €40.1bn. The latest transaction was disclosed on 19 August 2025 (Cession). Among the most active insiders: Mayer Jessica L. Every trade is openly available.
194
Insider Decl.
0
Thresholds
€28,928
3 ops.
Buy Volume
€11m
8 ops.
Sell Volume
27Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,874 of 25,535 companies
38.5
score / 100
Value61
Quality16
FCF yld4.6%
Earn yld3.9%
EV/EBITDA·
ROE·
Gross mgn3.7%
Net mgn0.7%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 August 2025
Declarations194 total
34,455 shares@ US$148.6139.7% of flowCommon SharesSEC:0000721371-25-000093:2
11,363 shares0Common SharesSEC:0000721371-25-000093:0
34,866 shares@ US$150.2240.6% of flowCommon SharesSEC:0000721371-25-000093:1
13,788 shares@ US$149.1916.0% of flowCommon SharesSEC:0000721371-25-000093:3
67,448 shares0Common SharesSEC:0000721371-25-000080:0
1,049 shares0Common SharesSEC:0000721371-25-000030:0
1,049 shares0Common SharesSEC:0000721371-25-000029:0
1,919 shares@ US$126.212.1% of flowCommon SharesSEC:0000721371-25-000017:0
636 shares@ US$126.2113.1% of flowCommon SharesSEC:0000721371-25-000015:0
90 shares@ US$122.240.9% of flowCommon SharesSEC:0000721371-24-000164:0
632 shares@ US$122.242.1% of flowCommon SharesSEC:0000721371-24-000166:0
676 shares@ US$122.241.1% of flowCommon SharesSEC:0000721371-24-000165:0
355 shares@ US$122.240.8% of flowCommon SharesSEC:0000721371-24-000163:0
5,186 shares@ US$121.298.6% of flowCommon SharesSEC:0000721371-24-000156:0
3,504 shares@ US$123.5537.3% of flowCommon SharesSEC:0000721371-24-000154:0
2,812 shares0Common SharesSEC:0000721371-24-000146:0
1,730 shares0Common SharesSEC:0000721371-24-000152:0
1,730 shares0Common SharesSEC:0000721371-24-000144:0
1,730 shares0Common SharesSEC:0000721371-24-000149:0
1,730 shares0Common SharesSEC:0000721371-24-000148:0
1,730 shares0Common SharesSEC:0000721371-24-000145:0
1,730 shares0Common SharesSEC:0000721371-24-000147:0
1,730 shares0Common SharesSEC:0000721371-24-000150:0
1,730 shares0Common SharesSEC:0000721371-24-000151:0
16,573 shares@ US$109.3923.4% of flowCommon SharesSEC:0000721371-24-000089:0
25 of 194 declarations
About CARDINAL HEALTH INC
Cardinal Health Inc. is a major U.S. healthcare services and products company listed on the NYSE under ticker CAH, and headquartered in Dublin, Ohio, United States. Founded in 1971, the company has evolved into one of the most important players in the American healthcare supply chain, with a long-standing franchise in pharmaceutical distribution and a broader platform serving hospitals, pharmacies, physician offices, laboratories, ambulatory surgery centers, and patients at home. Cardinal Health reports two main operating segments. Pharmaceutical and Specialty Solutions is its largest and most strategically important business, centered on the distribution of branded, generic, and specialty pharmaceuticals, along with supporting services for manufacturers and healthcare providers. Global Medical Products and Distribution (GMPD) covers medical products, hospital supplies, and distribution solutions. In addition, the company groups several growth-oriented businesses under “Other,” including Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight Logistics. This portfolio mix shows a deliberate attempt to complement the low-margin but high-scale distribution core with higher-growth, higher-value healthcare services. From a competitive standpoint, Cardinal Health is one of the key U.S. pharmaceutical distributors, operating in an industry characterized by scale, logistics intensity, and tight margins. Its competitive advantages include national reach, purchasing and fulfillment capabilities, deep customer relationships, and the ability to provide integrated solutions across the healthcare value chain. The company also benefits from exposure to specialty pharmacy, patient support, home delivery, nuclear pharmacy operations, and data/performance solutions, which can support long-term earnings diversification. Recent developments have been strategically meaningful. In 2025, Cardinal Health announced and then completed the acquisition of Solaris Health, a leading urology MSO, strengthening The Specialty Alliance and expanding its multi-specialty management-services platform. It also completed the acquisition of Advanced Diabetes Supply Group, reinforcing its at-Home Solutions franchise. More recently, management raised its fiscal 2026 outlook and highlighted continued momentum across all five operating segments, alongside ongoing investments in automation, distribution capacity, and network optimization. For international investors, CAH remains a mature but actively transforming U.S. healthcare name, with a balance of defensive distribution exposure and selective growth optionality in specialty and home-based care.
